To the Editor—Central venous catheters (CVCs) are indispensable in hematopoietic stem cell transplant practice. With the increasing burden of multidrug-resistant bacterial organisms (MDROs) in communities worldwide, the risk of CVC colonization and subsequent life-threatening bloodstream infections (BSI) with these organisms poses a serious threat to transplant practice.Reference Bhattacharya, Goel, Mukherjee, Bhaumik and Chandy ^{1 ,} Reference Bhattacharya, Das, Bhalchandra and Goel ² Hence, safety management of central lines presents major challenges in the setting of hematological disorders. We evaluated our experience with CVC MDRO colonization and bacteremia at the stem cell transplant (SCT) unit in the Tata Medical Center, Kolkata, India.

A retrospective cohort analysis was conducted from December 2011 to June 2015. Patients were nursed in single en-suite high-efficiency particulate air (HEPA)–filtered rooms. The air quality of each bone-marrow-transplant room was maintained using a separate air handling unit; air quality was checked using a hand-held air particle counter; air velocity was measured using an anemometer, and air pressure was monitored using a differential pressure monitor.Reference Bhalchandra, Bhattacharya, Ratnam Soundaranayagam, Garai and Chandy ³ Water quality in the SCT rooms was maintained using Pall filters for shower heads and taps. These filters have a 0.2-µm pore size and provide a protective barrier against waterborne contaminants including Legionella spp., and Pseudomonas spp., and other bacteria (coliforms). The water quality of the hospital is maintained through reverse osmosis and chlorination (free chlorine, 0.2–0.5 ppm).Reference Bhalchandra, Chandy, Ramanan, Mahajan, Soundaranayagam, Garai and Bhattacharya ⁴

The patient:nurse ratio in the SCT unit was 1:1.5. Nurses in the SCT unit were trained using the World Health Organization (WHO) module of hand hygiene, preparation and administration of medicines (drugs, blood products) under aseptic techniques, and CVC dressing protocol, as well as standard precautions. Housekeeping (environmental cleaning) practices included a 3-shift cleaning protocol using soap and water and sodium hypochlorite (for floors); 10% hydrogen peroxide (for all surfaces pre-admission and post discharge); and alcohol (isopropyl alcohol and ethyl alcohol for beds, steel surfaces, and biomedical equipment). Before insertion of a CVC, each patient was given a bath with 4% chlorhexidine in addition to soap and water. The CVC care bundle included sterile insertion under maximum barrier precautions, daily change of infusion sets, gauze or transparent dressing, flushing and locking, as well as the use of an ELD96 filter (Pall) for total parenteral nutrition and a Lipipor filter (Pall) for parenteral lipids. We also used a leucodepletion filter for packed cells and platelets. A dose of antibiotic (co-amoxiclav) was given pre-operatively within 60 minutes of CVC insertion. CVCs were inserted a few days prior to transplant, and where feasible, most CVCs were removed within 90 days of insertion. Skin preparation before insertion was done using 2.5% chlorhexidine with isopropyl alcohol 70% (or 10% povidone iodine). Patients and family members were educated to take care of the central line at home and to report to the outpatient department for heparinized flushing, blood sampling, and dressing weekly. Before accessing the line, meticulous hub scrubbing was done for 20–30 seconds with 2.5% chlorhexidine and 70% isopropyl alcohol. The line sites were evaluated on every shift for signs of inflammation and infection of the exit site. Bed linens for each the patient were sterilized by autoclaving and changed daily. Patients were provided with a “neutropenic diet” (pressure cooked food and water). Stem cells were collected, stored, and infused under aseptic techniques. All cases of clinical sepsis and positive blood cultures were proactively treated using a protocol of empirical therapy (piperacillin-tazobactam+amikacin > meropenem+teicoplanin > meropenem+colistin), and positive blood culture directed early therapy based on Gram-stain findings and preliminary sensitivity.Reference Goel, Das, Mukherjee, Bose, Das, Mahato and Bhattacharya ⁵

During the study period, a total of 170 CVCs were placed in 163 patients to support 172 transplants, including 112 allogeneic procedures. Nearly one-third of allogeneic transplants (36 of 112) were high risk, including HLA haplotype–matched procedures (28 of 112) and matched–unrelated donor procedures (8 of 112). The median age of patients was 32 years (range, 2–66 years), 123 (75%) were male. The majority of CVCs were tunneled devices (Hickman catheters; 113 of 170); the rest were peripherally inserted central lines (PICCs; 10 of 170) and non-tunneled central lines (47 of 170) inserted into jugular or subclavian veins. Pre-transplant surveillance cultures of stool and throat swabs identified MDROs in 145 (87%) and 42 (26%) patients, respectively.Reference Landman, Salvani, Bratu and Quale ⁶ Stool surveillance showed ESBL in 87 patients (60%), carbapenemase producers in 43 patients (30%), AmpC producers in 26 patients (18%), and VRE in 4 patients (2.7%). Throat surveillance showed carbapenemase producers in 23 patients tested (55%), ESBL in 17 patients (40%), AmpC producers in 4 patients (9.5%), and VRE in 1 patient (2.3%) (Table 1).

TABLE 1 Distribution of Multidrug-Resistant Organisms (MDROs) in Surveillance Cultures

NOTE. ESBL, extended-spectrum β-lactamase; AmpC, a type of β-lactamase; VRE, vancomycin- resistant enterococcus.

The median duration of neutropenia (≤500/mm³) was 11 days (3–36 days). A cumulative 11,410 CVC days were recorded, with a median 58 days per patient (range, 8–418 days, interquartile range, 18–89 days). A total of 36 BSIs were observed, including 9 isolates identified in pre-transplant cultures (7 from stool, 2 from throat swabs). A total of 19 BSIs were associated with mucosal barrier injury (MBI-LCBI: mucosal barrier injury–laboratory-confirmed bloodstream infection).Reference Metzger, Rucker, Callaghan, Churchill, Jovanovic, Zembower and Bolon ⁷ Thus, 17 BSIs were associated with central-line infection, with a CLABSI rate of 1.48 per 1,000 catheter days. In addition, 7 (4%) lines were removed for various reasons (eg, exit-site infection, tip migration, fracture of the line). No CVC was removed because of CLABSI.

Despite a high rate of MDRO colonization, a low incidence of catheter-associated bacteremia was observed in patients undergoing stem cell transplant at our center. This finding suggests that in high-intensity clinical settings, despite the high prevalence of MDROs, a combination of rigorous central venous catheter care and concerted infection vigilance ensures low catheter-associated bloodstream infection rates. Coordinated team work among various multi-disciplinary teams (ie, maintenance engineering, nursing, housekeeping, infection control, SCT unit doctors and central sterile supply department, transfusion medicine department, patients and relatives) led the way to attaining a satisfactory outcome in this challenging setting.